Neurological Manifestations of Histiocytic Disorders.


Journal

Current neurology and neuroscience reports
ISSN: 1534-6293
Titre abrégé: Curr Neurol Neurosci Rep
Pays: United States
ID NLM: 100931790

Informations de publication

Date de publication:
Jun 2023
Historique:
accepted: 04 04 2023
medline: 12 6 2023
pubmed: 20 5 2023
entrez: 20 5 2023
Statut: ppublish

Résumé

Histiocytic disorders, including Erdheim-Chester disease (ECD), Langerhans cell histiocytosis (LCH), and Rosai-Dorfman disease (RDD), are rare neoplasms that may present with a spectrum of neurologic involvement. Diagnostic delay is common due to heterogeneity in presentation and challenging pathology. Recent advances in the treatment of these diseases targeted towards mutations in the MAP kinase pathway have led to an improved prognosis in these patients with neurologic involvement. It is critical for clinicians to have a high index of suspicion to allow for early targeted treatment and optimize neurologic outcomes. A systematic approach to diagnosis is presented in this article to allow for accurate diagnosis of these rare diseases.

Identifiants

pubmed: 37209319
doi: 10.1007/s11910-023-01272-4
pii: 10.1007/s11910-023-01272-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

277-286

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Samantha A Banks (SA)

Department of Neurology, Mayo Clinic Rochester, 200 First St SW, Rochester, MN, 55905, USA.

Julio C Sartori Valinotti (JC)

Department of Dermatology, Mayo Clinic Rochester, Rochester, MN, USA.

Ronald S Go (RS)

Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

Jithma P Abeykoon (JP)

Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

Gaurav Goyal (G)

Division of Hematology-Oncology, The University of Alabama at Birmingham, Birmingham, AL, USA.

Jason R Young (JR)

Department of Radiology, Mayo Clinic in Jacksonville, Jacksonville, FL, USA.

Matthew J Koster (MJ)

Division of Rheumatology, Mayo Clinic Rochester, Rochester, MN, USA.

Robert Vassallo (R)

Division of Pulmonary and Critical Care Medicine, Mayo Clinic Rochester, Rochester, MN, USA.

Jay H Ryu (JH)

Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

Caroline J Davidge-Pitts (CJ)

Division of Endocrinology, Mayo Clinic Rochester, Rochester, MN, USA.

Aishwarya Ravindran (A)

Division of Laboratory Medicine-Hematopathology, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.

N Nora Bennani (NN)

Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

Mithun V Shah (MV)

Division of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.

Karen L Rech (KL)

Division of Hematopathology, Mayo Clinic Rochester, Rochester, MN, USA.

W Oliver Tobin (WO)

Department of Neurology, Mayo Clinic Rochester, 200 First St SW, Rochester, MN, 55905, USA. tobin.oliver@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH